ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

SLDB Solid Biosciences Inc

8.98
0.44 (5.15%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 189,872
Bid Price 7.44
Ask Price 9.50
News -
Day High 9.08

Low
1.81

52 Week Range

High
15.05

Day Low 8.41
Share Name Share Symbol Market Stock Type
Solid Biosciences Inc SLDB NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.44 5.15% 8.98 17:59:54
Open Price Low Price High Price Close Price Previous Close
8.52 8.41 9.08 8.98 8.54
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
2,141 189,872 US$ 8.80 US$ 1,671,066 - 1.81 - 15.05
Last Trade Type Quantity Price Currency
15:01:01 formt 1,034 US$ 8.97 USD

Solid Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
339.06M 37.76M - 0 -96.02M -2.54 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Solid Biosciences News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SLDB Message Board. Create One! See More Posts on SLDB Message Board See More Message Board Posts

Historical SLDB Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week9.139.617.958.82223,248-0.15-1.64%
1 Month13.4713.477.9510.50189,880-4.49-33.33%
3 Months6.7315.056.5411.16254,9852.2533.43%
6 Months2.0415.051.816.50458,8536.94340.20%
1 Year4.5515.051.816.39239,3904.4397.36%
3 Years77.2581.901.8125.60549,635-68.27-88.38%
5 Years141.00203.701.8155.11846,126-132.02-93.63%

Solid Biosciences Description

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of speciality and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. Its lead product candidate, the SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles. The company's pipeline products are the SB-001 and solid suit. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Your Recent History

Delayed Upgrade Clock